Science Current Events | Science News | Brightsurf.com
 

Stent Graft Current Events | Stent Graft News

Page 1 of 10 | 229 Results
Previous01020304050607080910   Next   
Sort By: Page Views | Date
'Stent-Graft' procedure improves outcomes of carotid aneurysm repair
For patients with life-threatening aneurysms of the carotid artery in the neck, a minimally invasive stent-grafting technique can be just as effective as traditional open surgery, but with faster recovery and fewer complications, according to a study in the March Journal of Vascular Surgery.   view more (2006-03-08)

NYC first: Complex aneurysm treated using new fenestrated endograft stent
In a New York City metro-area first, a 93-year-old Bronx man underwent implantation of a new stent graft at NewYork-Presbyterian Hospital, the only center on the Eastern Seaboard with access to this investigational device.   view more (2008-07-08)

Stent-Grafts: A safe therapeutic option for patients with impending rupture of the chest aorta
IMPORTANT: This press release accompanies a poster or oral session given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology True aneurysms and dissecting aneurysms (see figure 1) of... view more (2003-08-31)

Multidetector CT: Non-Invasive Alternative to Bronchoscopy in Patients with Airway Stent Complications
Multidetector CT (MDCT) scans are highly accurate in detecting airway stent complications according to a recent study performed at Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, MA.   view more (2008-11-04)

Study confirms that stents releasing medication help keep heart bypass vein grafts open
Stents can be inserted into a grafted vein or into a native coronary artery during a balloon angioplasty procedure.   view more (2005-12-02)

NEW THERAPEUTIC APPROACH TO CORONARY STENTING (p 2037)
Patients given stent implantation to treat coronary heart disease could benefit from a new therapeutic approach with the platelet glycoprotein IIb/IIIa inhibitor eptifibatide, concludes research published in this week's issue of THE LANCET. The platelet glycoprotein IIb/IIIa inhibitors are potent... view more (2000-12-13)

Antibodies can halve risk of transplant rejection
Giving interleukin-2 receptor antibodies to patients after a kidney transplant can halve the risk of rejection, concludes a study in this week's BMJ. Researchers in Birmingham reviewed eight trials of interleukin-2 receptor antibodies versus placebo in 1,858 patients receiving standard... view more (2003-04-10)

Fewer adverse cardiac events at one year
Late breaking results from the SPIRIT III trial, presented at TCT 2007, the annual scientific symposium of the Cardiovascular Research Foundation, show that after 12 months, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or... view more (2007-10-24)

Study Finds Half of Patients Undergoing Cerebrovascular Stent Placement Respond Poorly to the Antiplatelet Drug Clopidogrel (Plavix)
A study by researchers at Rush University Medical Center, published in the February issue of the American Journal of Neuroradiology, finds that half of patients undergoing cerebrovascular stent placement did not respond well to clopidogrel. Clopidogrel (Plavix) and aspirin are medications routinely... view more (2008-02-06)

Donor T cells change the fate of stem cells in transplantation
When a transplant patient suffers complications such as graft rejection or graft-versus-host disease, physicians attempt to stop the body's immune response by targeting a patient's T cells.   view more (2006-07-13)

Primary graft dysfunction is risk factor for a later serious lung transplant problem
Primary graft dysfunction, a common complication that affects up to 25 percent of lung transplant patients shortly after surgery, constitutes a significant risk factor for later deadly bronchiolotis obliterans syndrome (BOS).   view more (2007-03-01)

Comparison of drug-releasing coronary stents show similar effectiveness
Use of coronary stents that release the drugs sirolimus or paclitaxel produced similar results in patients with new coronary artery lesions, according to a study in the February 22 issue of JAMA.   view more (2006-02-22)

The Lancet publishes first clinical trial data of a fully bioabsorbable drug eluting stent
Data published today in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and... view more (2008-03-14)

Sirolimus-eluting Coronary Stent is cost effective vs. bypass surgery
An independent analysis of a clinical trial comparing the cost-effectiveness of the CYPHER¬Æ Sirolimus-eluting Coronary Stent vs. bypass surgery suggests that treatment with the CYPHER¬Æ Stent offers a potential cost-savings over bypass surgery.   view more (2005-10-21)

Early reports of thrombosis after insertion of drug-eluting stent (pp 1466, 1519)
Authors of a research letter in this week's issue of THE LANCET highlight how the use of drug-eluting stents (DES) may carry a risk of subsequent thrombosis if stenting is accompanied by a withdrawal of antiplatelet therapy.   view more (2004-10-20)

Value of stent-coating drugs questioned
Patients admitted to the hospital with acute coronary syndromes (ACS) are often treated with a catheter-based procedure known as percutaneous coronary intervention (PCI), during which a stent is inserted into an occluded or narrowed coronary artery to restore blood flow to and from the heart.   view more (2007-03-27)

Jefferson vascular surgeon heads national trial for torn aorta repair
Tears in the aorta which affect thousands of people each year coast to coast, may soon be treated with a much less invasive technique that could dramatically improve patients' chances of survival.   view more (2007-12-13)

How about the feasibility of endoscopic ultrasonography-guided choledochoduodenostomy?
Endoscopic ultrasonography (EUS)-guided biliary drainage for treatment of patients who have obstructive jaundice in cases of failed endoscopic retrograde cholangiopancreatography (ERCP).   view more (2008-11-03)

Cerebral embolic protection and carotid stent systems
High-risk surgical patients in community hospital settings can safely benefit from the use of new embolus-removing and stent-inserting systems, according to a study presented today at the American College of Cardiology's Innovation in Intervention: i2 Summit in New Orleans, La.   view more (2007-03-27)

Stent Or Bypass Surgery For Coronary Artery Disease?
An international study in this week`s issue of THE LANCET highlights how patients given bypass surgery for blocked or narrowed coronary arteries are less likely to require further intervention than patients given stent-assisted balloon angioplasty. The study also reported an apparent survival... view more (2002-09-25)

ESC Congress 2003: 6 months result of a non-polymeric paclitaxel eluting stent in high-risk lesions
IMPORTANT: This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: Hot Line II -... view more (2003-09-01)

Drug-eluting stents more effective, equally as safe as bare metal stents in clinical trial
Late-breaking data from the HORIZONS AMI (Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction) trial reveal that after one year, use of a drug-eluting (paclitaxel) stent demonstrated significantly reduced rates of target lesion revascularization (TLR) and binary... view more (2008-10-16)

Early promise for steroid-free liver transplantation in children (p 2068)
Results of a preliminary study into paediatric liver transplantation in this week's issue of THE LANCET suggest that successful transplantation could take place without the need for steroid treatment-with potential health benefits for transplant recipients. Steroids have been central to... view more (2003-12-17)

Comparison of anticoagulants for angioplasty show similar outcomes
In a comparison of anticoagulants and stents for use with angioplasty following a heart attack, the anticoagulants abciximab and tirofiban had similar outcomes for some cardiac measures within 90 minutes after the procedure, while patients who received stents that released the drug sirolimus had a... view more (2008-03-31)

Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients
A study showing that diabetic patients who are treated with long-term anti-clotting therapy are less likely to have a heart attack or die more than a year after stenting has been named among the best research papers presented at the 30th Annual Scientific Sessions of the Society for Cardiovascular... view more (2007-05-18)
Page 1 of 10 | 229 Results
Previous01020304050607080910   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com